[Federal Register Volume 67, Number 200 (Wednesday, October 16, 2002)]
[Notices]
[Pages 63933-63934]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-26325]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Infant Formula Subcommittee of the Food Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Infant Formula Subcommittee of the Food Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on scientific issues and principals 
related to FDA's regulatory issues.
    Date and Time: The meeting will be held on November 18, 2002, from 
8 a.m. to 6 p.m. and November 19, 2002, from 8 a.m. to 5 p.m.
    Location: U.S. Department of Agriculture, Animal and Plant Health 
Inspection Service, Conference Center, 4700 River Rd., Riverdale, MD, 
301-734-8010.
    Contact Person: Jeanne E. Latham, Center for Food Safety and 
Applied Nutrition (HFS-800), Food and Drug Administration, 5100 Paint 
Branch Pkwy., College Park, MD 20740, 301-436-1756, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 10564. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The meeting's purpose is to discuss the scientific issues 
and principles involved in assessing and evaluating whether a ``new'' 
infant formula supports normal physical growth in infants when consumed 
as a sole source of nutrition. This is the second meeting of a series 
of advisory committee meetings to discuss the scientific issues 
involved in evaluating whether a new infant formula supports normal 
physical growth.
    FDA will post information relating to this meeting on the Internet 
at http://www.cfsan.fda.gov/[tilde]lrd/vidtel.html.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by November 1, 
2002. Oral presentations from the public will be scheduled between 
approximately 8:30 a.m. and 9:30 a.m. on November 19, 2002. Time 
allotted for each presentation may be limited. Those desiring to make 
formal oral presentations should notify the contact person before 
November 13, 2002, and submit a brief statement of the general nature 
of the evidence or arguments they wish to present, the names and 
addresses of proposed participants, and an indication of the 
approximate time requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Jeanne E. Latham at 
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).


[[Page 63934]]


    Dated: October 9, 2002.
Linda Arey Skladany,
Senior Associate Commissioner for External Relations.
[FR Doc. 02-26325 Filed 10-15-02; 8:45 am]
BILLING CODE 4160-01-S